corona vaccine The long-awaited BBV152 Covid-19 Vaccine or Covaxin Clinical Trial has begun at the Institute of Medical Sciences and SUM Hospital, one of 12 centres selected by the Indian Council of Medical Research (ICMR).
Good news is coming from Odisha regarding the vaccine preparation in the country in the fight against coronavirus. Covaxin has begun clinical trials on humans under the Indian Council of Medical Research (ICMR) and Bharat Biotech’s General Program. Even better, no side effects were reported after vaccination.
The long-awaited BBV152 Covid-19 Vaccine or covaccine Clinical Trial has begun at the Institute of Medical Sciences and SUM Hospital, one of the 12 centres selected by the Indian Council of Medical Research (ICMR). These 12 centres have been selected for the first and second phase of the process, according to an agency official.
Bharat Biotech is developing covaxin for a select few who have come forward to be part of this important test, said Dr. E. Venkata Rao, Principal Investigator of the Test Process. All those who have been vaccinated are under observation and said they have seen a good recovery in their health.
Rao said that the volunteers who came forward to get the vaccine had to go through a rigorous screening process and follow the protocol set by the Drug Controller General of India (DCGI). The selected volunteers will be given two doses over a period of 14 days, he explained.
A professor in the hospital’s community medicine department said there was a lot of excitement among the people who came to the test. There has been a very encouraging response from people. He said many people are still coming forward to be part of the test.